MedTrace Logo

Effectiveness of Smoking-cessation Interventions for Urban Hospital Patients

NCT01363245 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1618

Last updated 2015-07-02

No results posted yet for this study

Summary

The investigators plan to compare the effectiveness and cost effectiveness of an inpatient smoking cessation intervention for all smokers hospitalized at two urban public hospitals.

Conditions

  • Smoking Cessation

Interventions

BEHAVIORAL

Telephone Counseling

Telephone counseling: 7 calls over 6 weeks

BEHAVIORAL

Fax-to-quit

referral to state smoking cessation 'quitline' for counseling - 1 call over 2 weeks

Sponsors & Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

    collaborator NIH

  • NYU Langone Health

    lead OTHER

Principal Investigators

  • Scott E Sherman, MD, MPH · NYU School of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-07-31
Primary Completion
2014-12-31
Completion
2015-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01363245 on ClinicalTrials.gov